GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OSTO:CAMX) » Definitions » Cyclically Adjusted PS Ratio

Camurus AB (OSTO:CAMX) Cyclically Adjusted PS Ratio : 60.32 (As of Jun. 09, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Camurus AB Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Camurus AB's current share price is kr599.00. Camurus AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr9.93. Camurus AB's Cyclically Adjusted PS Ratio for today is 60.32.

The historical rank and industry rank for Camurus AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

OSTO:CAMX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 46.35   Med: 53.85   Max: 61.97
Current: 60.32

During the past years, Camurus AB's highest Cyclically Adjusted PS Ratio was 61.97. The lowest was 46.35. And the median was 53.85.

OSTO:CAMX's Cyclically Adjusted PS Ratio is ranked worse than
93.45% of 504 companies
in the Biotechnology industry
Industry Median: 5.47 vs OSTO:CAMX: 60.32

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Camurus AB's adjusted revenue per share data for the three months ended in Mar. 2024 was kr6.599. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr9.93 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Camurus AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Camurus AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Cyclically Adjusted PS Ratio Chart

Camurus AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 56.77

Camurus AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 56.77 51.10

Competitive Comparison of Camurus AB's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Camurus AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Camurus AB's Cyclically Adjusted PS Ratio falls into.



Camurus AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Camurus AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=599.00/9.93
=60.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camurus AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Camurus AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.599/132.2054*132.2054
=6.599

Current CPI (Mar. 2024) = 132.2054.

Camurus AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 0.000 100.541 0.000
201409 0.831 100.161 1.097
201412 3.541 100.225 4.671
201503 2.127 99.950 2.813
201506 0.554 99.995 0.732
201509 0.910 100.228 1.200
201512 0.892 100.276 1.176
201603 0.497 100.751 0.652
201606 0.633 101.019 0.828
201609 0.743 101.138 0.971
201612 0.903 102.022 1.170
201703 0.418 102.022 0.542
201706 0.463 102.752 0.596
201709 0.299 103.279 0.383
201712 0.130 103.793 0.166
201803 0.382 103.962 0.486
201806 0.190 104.875 0.240
201809 0.489 105.679 0.612
201812 0.149 105.912 0.186
201903 0.426 105.886 0.532
201906 0.223 106.742 0.276
201909 0.798 107.214 0.984
201912 0.689 107.766 0.845
202003 0.920 106.563 1.141
202006 1.510 107.498 1.857
202009 1.804 107.635 2.216
202012 1.894 108.296 2.312
202103 2.263 108.360 2.761
202106 2.467 108.928 2.994
202109 2.715 110.338 3.253
202112 3.226 112.486 3.792
202203 3.884 114.825 4.472
202206 3.981 118.384 4.446
202209 4.186 122.296 4.525
202212 4.654 126.365 4.869
202303 4.937 127.042 5.138
202306 11.729 129.407 11.983
202309 6.679 130.224 6.781
202312 6.517 131.912 6.532
202403 6.599 132.205 6.599

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Camurus AB  (OSTO:CAMX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Camurus AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Camurus AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB (OSTO:CAMX) Business Description

Industry
Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.

Camurus AB (OSTO:CAMX) Headlines